Professional Planning’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Professional Planning’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$209K	Sell	1,665 -157	-9%	-$20.2K	0.1%	121
2021 Q2	$246K	Sell	1,822 -298	-14%	-$39.2K	0.11%	121
2021 Q1	$287K	Sell	2,120 -68	-3%	-$10.2K	0.14%	96
2020 Q4	$308K	Buy	+2,188	New	+$280K	0.12%	100
2020 Q3	–	Sell	-1,890	Closed	-$212K	–	110
2020 Q2	$212K	Buy	+1,890	New	+$186K	0.11%	109

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Professional Planning's XBI Position: Q3 2021 in Review

Professional Planning reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 8.6% in Q3 2021, selling an estimated $20.2K and leaving 1,665 shares worth $209K. The position accounts for 0.1% of the portfolio, ranked #121.

Professional Planning first reported a position in XBI in Q2 2020 and has held it in 5 quarters since. The position peaked at $308K in Q4 2020. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

Professional Planning held 1,665 shares of State Street SPDR S&P Biotech ETF worth $209K as of Q3 2021.
Professional Planning sold 157 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $20.2K.
State Street SPDR S&P Biotech ETF made up 0.1% of Professional Planning's portfolio in Q3 2021, its #121 holding.
Professional Planning first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 5 quarters since.
Professional Planning's State Street SPDR S&P Biotech ETF position peaked at $308K in Q4 2020.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on Professional Planning's 13F filing for Q3 2021, filed 15 Nov 2021.